|
Sunday, 08/01/2010
|
Tests for Conditional Association Between an Ordinal Predictor and Continuous, Binomial, or Ordinal Outcomes
Bryan E. Shepherd, Vanderbilt University; Chun Li, Vanderbilt University
3:05 PM
|
On the Use of Adjusted Cross-Sectional Estimators of HIV Incidence
Rui Wang, Harvard School of Public Health; Stephen Lagakos, Harvard School of Public Health
4:05 PM
|
Comparison of the Effectiveness of Three Novel Statistical Methods for Biomarker Selection with Application to an HIV Infection Data Set
Bosny J. Pierre-Louis, The University of North Carolina at Chapel Hill
4:05 PM
|
Statistical Methods for Missing Partnership Data in HIV Transmission Research
Ayn Leslie-Cook, University of Washington
4:25 PM
|
Effect of Hormonal Contraception on the HIV Acquisition Using Structural Models
Pai-Lien Chen, Family Health International
5:35 PM
|
|
Monday, 08/02/2010
|
In Vitro Drug Combination Analysis in Excel: A Case Study in HIV
Karen Chiswell, GlaxoSmithKline; Katja Sabine Remlinger, GlaxoSmithKline; Mark Underwood, GlaxoSmithKline
|
Augmented Cross-Sectional Studies with Abbreviated Follow-Up for Estimating HIV Incidence
Brian Claggett, Harvard School of Public Health
|
Global Drug Development in a Rapidly Changing World, with Examples from HCV/HIV Trials
Regis Vilchez, Merck Research Laboratories; Carmen Mak, Merck Research Laboratories
9:35 AM
|
Statistical Design for a Small Serial Dilution Series
Daniel Zelterman, Yale University
2:25 PM
|
A Joint Longitudinal and Illness-Death Model
Elizabeth Renata Brown, University of Washington
2:25 PM
|
Evaluation of Design Parameters for an Adaptive Seamless Phase 2b/3 Trial
Susan Y. Zhou, CDER/FDA; Greg Soon, CDER/FDA; Xiao Ding, CDER/FDA; JungYeon Park, CDER/FDA; EunYoung Kim, CDER/FDA; Sue-Jane Wang, FDA
3:05 PM
|
|
Tuesday, 08/03/2010
|
A NONMEM Population Approach to Modeling the Pharmacogenetics of Atazanavir and Ritonavir in HIV-Negative Adults
Deidre A. Kile, Colorado School of Public Health, University of Colorado Denver; Samantha MaWhinney, Colorado School of Public Health, University of Colorado Denver; Joseph E. Rower, University of Colorado, Denver; Peter L. Anderson, University of Colorado, Denver
|
A Natural B-Spline Varying-Coefficient Method for Longitudinal Data with Nonignorable Dropout
Jeri E.F. Harwood, University of Colorado, Denver; Samantha MaWhinney, Colorado School of Public Health, University of Colorado Denver; Erika L. Hernandez, Brigham Young University
|
Accounting for Dropout in Longitudinal Cohort Studies
Timothy Bahr, Colorado School of Public Health, University of Colorado Denver; Samantha MaWhinney, Colorado School of Public Health, University of Colorado Denver; Jeri E.F. Harwood, University of Colorado, Denver; Erika L. Hernandez, Brigham Young University; Eric Benotsch, Virginia Commonwealth University; Elizabeth Connick, University of Colorado, Denver
|
Cluster Analysis Investigation of Video Streams and Archives
Brett Amidan, Pacific Northwest National Laboratory; Harold Trease, Pacific Northwest National Laboratory
8:35 AM
|
Analysis Strategies for Pooled Nucleic Acid Testing to Identify Antiretroviral Treatment Failure During HIV Infection
Susanne May, University of Washington; Tanya Granston, University of Washington; Davey Smith, University of California, San Diego
8:55 AM
|
Using IV with Subjective Assumptions to Construct Treatment Effect Bounds on Continuous Outcomes in Observational Studies
Joseph W. Hogan, Brown University; Tao Liu, Brown University
2:05 PM
|
Incorporating Sampling Bias in Analyzing Bivariate Survival Data with Interval Sampling and Application to HIV Research
Hong Zhu, Johns Hopkins Bloomberg School of Public Health; Mei-Cheng Wang, The Johns Hopkins University
2:25 PM
|
|
Wednesday, 08/04/2010
|
A Bayesian Generalized Linear Mixed Model for HIV-1 Vaccine Immune Response with Missing Data
Sydeaka Patrice Watson, Baylor University; John Seaman, Baylor University; James Stamey, Baylor University; Bette Korber, Los Alamos National Laboratory; Mark Muldoon, University of Manchester
|
Individually Randomized Group Treatment (IRGT) Trials in HIV/AIDS: How Often Is the Intraclass Correlation Ignored in Design and Analysis?
Sherri L. Pals, CDC; Ryan E. Wiegand, CDC; David Murray, The Ohio State University
8:35 AM
|
Group-Randomized Trials (GRT) in HIV/AIDS Research: How Often Is the Intraclass Correlation Ignored in Design and Analysis?
Ryan E. Wiegand, CDC; Sherri L. Pals, CDC; David Murray, The Ohio State University
8:55 AM
|
The Bayesian Hierarchical Model for Estimating the Size of HIV At-Risk Populations in Bangladesh
Le Bao, University of Washington; Adrian E. Raftery, University of Washington; Amala Reddy, UNAIDS Regional Support Team Asia-Pacific
9:20 AM
|
Meta-Analysis of Survey Data to Estimate the Size of the Population of Men Who Have Sex with Men for Calculating HIV Rates
Christopher H. Johnson, CDC; David Purcell, CDC; Amy Lansky, CDC; Joseph Prejean, CDC; Paul Denning, CDC; Nicole Crepaz, CDC; Zaneta Gaul, CDC; Renee Stein, CDC; Zaneta Gaul, CDC
9:35 AM
|
Simultaneous Bayesian Inference for Skew-Normal Mixed-Effects Joint Models for Longitudinal Data
Yangxin Huang, University of South Florida
11:20 AM
|
Modeling Nested Multivariate Longitudinal Count Data with Application to HIV Behavioral Intervention
Yuda Zhu, University of California, Los Angeles; Robert E. Weiss, University of California, Los Angeles School of Public Health
3:05 PM
|
|